Disclosures for "New Tools to Improve Prediction of Clinical Outcomes After Endovascular Therapy for Patients with Large Infarct Core"
-
Ms. Waworuntu has nothing to disclose.
-
Dr. Lodhi has nothing to disclose.
-
Mr. Phan has nothing to disclose.
-
Ms. Mallavarapu has nothing to disclose.
-
Dr. Bajaj has nothing to disclose.
-
Dr. Kim has nothing to disclose.
-
Dr. Salazar-Marioni has nothing to disclose.
-
Luca Giancardo has received personal compensation for serving as an employee of AWS. Luca Giancardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rutgers University. Luca Giancardo has received intellectual property interests from a discovery or technology relating to health care. Luca Giancardo has received intellectual property interests from a discovery or technology relating to health care.
-
Prof. Shams has nothing to disclose.
-
Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
-
Dr. Aroor has stock in Gravity.
-
Mr. Jeevarajan has nothing to disclose.